Articles from FlatRx

FlatRx Publishes a Dated Price Comparison of Compounded Tirzepatide at 27 U.S. Telehealth Programs Counted at a 10 mg Weekly Dose
The comparison, read on November 17, 2026 from each program's own website, counts regular month-to-month prices, among other measures; at a 10 mg weekly dose, the regular month-to-month price of a FlatRx plan for compounded tirzepatide was the second least expensive of the 27 U.S. telehealth programs counted, with sale and first-month offers excluded. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products.
By FlatRx · Via ACCESS Newswire · November 21, 2026
Articles from FlatRx | FWNBC